EUVIMEDEUVIMED entdecken
Crossref

A comparative study on efficacy, safety and cost effectiveness analysis between vortioxetine and escitalopram in major depressive disorder

VS Vaishnavi, TV Pavan Kumar, R Valluru, Y Syamala, C Siva, R Bhavana

SA Pharmaceutical Journal · 01.04.2026 · 93 (2)

DOI: 10.36303/sapj.3549 ↗

Kurz gefasst

Fachartikel in der Zeitschrift SA Pharmaceutical Journal, erschienen am 01.04.2026. Verfasst von VS Vaishnavi und 5 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Vaishnavi, V., Kumar, T. P., Valluru, R., Syamala, Y., Siva, C., & Bhavana, R. (2026). A comparative study on efficacy, safety and cost effectiveness analysis between vortioxetine and escitalopram in major depressive disorder. SA Pharmaceutical Journal, 93(2). https://doi.org/10.36303/sapj.3549

Vancouver

Vaishnavi V, Kumar TP, Valluru R, Syamala Y, Siva C, Bhavana R. A comparative study on efficacy, safety and cost effectiveness analysis between vortioxetine and escitalopram in major depressive disorder. SA Pharmaceutical Journal. 2026;93(2). doi:10.36303/sapj.3549

BibTeX
@article{Vaishnavi2026,
  author = {Vaishnavi, VS and Kumar, TV Pavan and Valluru, R and Syamala, Y and Siva, C and Bhavana, R},
  title = {A comparative study on efficacy, safety and cost effectiveness analysis between vortioxetine and escitalopram in major depressive disorder},
  journal = {SA Pharmaceutical Journal},
  year = {2026},
  volume = {93},
  number = {2},
  doi = {10.36303/sapj.3549}
}
Kostenlos starten →